Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
Authors
Keywords
-
Journal
NEUROLOGY
Volume 98, Issue 7, Pages e688-e699
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-12-15
DOI
10.1212/wnl.0000000000013211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
- (2021) Adam M. Brickman et al. Alzheimers & Dementia
- African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
- (2021) Suzanne E. Schindler et al. Neurology-Genetics
- A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
- (2021) Tim West et al. Molecular Neurodegeneration
- Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers
- (2021) Shorena Janelidze et al. Alzheimers & Dementia
- Comparative analytical performance of multiple plasma amyloid‐beta assays and their relationship to amyloid PET
- (2021) Stephen Zicha et al. Alzheimers & Dementia
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy
- (2020) Kathryn Gauthreaux et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging
- (2020) James D. Doecke et al. Alzheimers Research & Therapy
- Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
- (2020) Reisa A. Sperling et al. JAMA Neurology
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Factors Associated with Lumbar Puncture Participation in Alzheimer’s Disease Research
- (2020) Madeleine M. Blazel et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer’s disease
- (2020) Kanta Horie et al. BRAIN
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
- (2018) Pierrick Bourgeat et al. NEUROIMAGE
- Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
- (2018) Leslie M. Shaw et al. Alzheimers & Dementia
- Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
- (2018) Itziar de Rojas et al. Alzheimers Research & Therapy
- The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics
- (2017) Lindsay K. Pino et al. MASS SPECTROMETRY REVIEWS
- Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
- (2016) Flora H. Duits et al. Alzheimers & Dementia
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience
- (2016) Jennifer C. Howell et al. Frontiers in Aging Neuroscience
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics
- (2013) Kwasi G. Mawuenyega et al. ANALYTICAL BIOCHEMISTRY
- Amyloid- Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
- (2012) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
- (2009) Kathryn A Ellis et al. INTERNATIONAL PSYCHOGERIATRICS
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started